Spotlight on Octreotide Long-Acting Release (LAR) in Acromegaly

By McKeage Kate   Cheer Susan   Wagstaff Antona J.  

Treatments in Endocrinology, Vol. 3, Iss. 3, 2004-01 ,pp. : 197-200

Adis International

Access to resources Recommend Favorite

Octreotide in the Treatment of Refractory Diarrhea

By  

Digestion, Vol. 60, Iss. 2, 1999-04 ,pp. : 42-46

Karger

Access to resources Recommend Favorite

Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids

By Jianu Constantin S.   Fossmark Reidar   Syversen Unni   Hauso ØØyvind   Fykse Vidar   Waldum Helge L.  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 4, 2011-04 ,pp. : 456-463

Informa Healthcare

Access to resources Recommend Favorite

Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis

By Omata Fumio   Deshpande Gautam   Tokuda Yasuharu   Takahashi Osamu   Ohde Sachiko   Carr-Locke David   Jacobs Joshua   Mine Tetsuya   Fukui Tsuguya  

Journal of Gastroenterology, Vol. 45, Iss. 8, 2010-08 ,pp. : 885-895

Springer Publishing Company

Access to resources Recommend Favorite

Albiglutide: clinical overview of a long-acting GLP-1 receptor agonist in the treatment of Type 2 diabetes

By Setji Tracy   Feinglos Mark  

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 3, 2013-05 ,pp. : 229-238

Informa Healthcare

Access to resources Recommend Favorite